JP2007538025A - エストラジオールプロドラッグ - Google Patents

エストラジオールプロドラッグ Download PDF

Info

Publication number
JP2007538025A
JP2007538025A JP2007517046A JP2007517046A JP2007538025A JP 2007538025 A JP2007538025 A JP 2007538025A JP 2007517046 A JP2007517046 A JP 2007517046A JP 2007517046 A JP2007517046 A JP 2007517046A JP 2007538025 A JP2007538025 A JP 2007538025A
Authority
JP
Japan
Prior art keywords
group
trien
sulfamoylbenzoate
hydroxyestradi
methoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007517046A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007538025A5 (de
Inventor
ビルバ，ラルフ
ドレーシャー，ペーター
リンク，スフェン
エルガー，バルター
シュナイダー，ビルギット
ヒリシュ，アレクサンダー
レデルセン，グドルン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Bayer Schering Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34969196&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP2007538025(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Schering Pharma AG filed Critical Bayer Schering Pharma AG
Publication of JP2007538025A publication Critical patent/JP2007538025A/ja
Publication of JP2007538025A5 publication Critical patent/JP2007538025A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2007517046A 2004-05-21 2005-05-10 エストラジオールプロドラッグ Pending JP2007538025A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004025966A DE102004025966A1 (de) 2004-05-21 2004-05-21 Estradiol-Prodrugs
PCT/EP2005/005254 WO2005113574A1 (de) 2004-05-21 2005-05-10 Aminosulfonyl- oder aminosulfonylamino-substituierte phenyl-ester als estradiol-prodrugs

Publications (2)

Publication Number Publication Date
JP2007538025A true JP2007538025A (ja) 2007-12-27
JP2007538025A5 JP2007538025A5 (de) 2008-06-26

Family

ID=34969196

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007517046A Pending JP2007538025A (ja) 2004-05-21 2005-05-10 エストラジオールプロドラッグ

Country Status (11)

Country Link
EP (1) EP1747230A1 (de)
JP (1) JP2007538025A (de)
AR (1) AR050335A1 (de)
DE (1) DE102004025966A1 (de)
GT (1) GT200500121A (de)
PA (1) PA8633701A1 (de)
PE (1) PE20060359A1 (de)
SV (1) SV2006002121A (de)
TW (1) TW200613315A (de)
UY (1) UY28909A1 (de)
WO (1) WO2005113574A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007538027A (ja) * 2004-05-21 2007-12-27 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト エストリオール及びエステトロールプロドラッグ類

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10027887A1 (de) 2000-05-31 2001-12-13 Jenapharm Gmbh Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
US7534780B2 (en) 2004-05-21 2009-05-19 Bayer Schering Pharma Aktiengesellschaft Estradiol prodrugs
DE102005057224A1 (de) * 2005-11-29 2007-05-31 Bayer Schering Pharma Ag Prodrugs ERß-selektiver Substanzen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE102005057225A1 (de) * 2005-11-29 2007-05-31 Bayer Schering Pharma Ag Prodrugs ERß-selektiver Substanzen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE102005057408A1 (de) * 2005-11-30 2007-05-31 Bayer Schering Pharma Ag Sulfamoylsulfonat-Prodrugs
AU2014287049B2 (en) * 2013-07-11 2019-09-26 Evestra, Inc. Pro-drug forming compounds
CN115368427B (zh) * 2022-08-17 2024-02-13 南宁师范大学 雌二醇硒氰酸酯类化合物及其制备方法与应用

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB915129A (en) * 1958-08-04 1963-01-09 Roussel Uclaf New steroid compounds and a process for their preparation
GB1272688A (en) * 1968-12-31 1972-05-03 Rech Chimiques Et Ind Mar Lab Sulphamido-steroids and the preparation thereof
WO2001081364A1 (fr) * 2000-04-24 2001-11-01 Kyowa Hakko Kogyo Co., Ltd. Derives d'estra-1,3,5(10)-triene
WO2002000679A2 (en) * 2000-06-28 2002-01-03 Novartis Ag 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-beta-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group
JP2003534386A (ja) * 2000-05-31 2003-11-18 シエーリング アクチエンゲゼルシャフト スルホンアミド基を有する化合物及びこれらの化合物を含む医薬組成物
WO2005005451A1 (en) * 2003-07-11 2005-01-20 Glaxo Group Limited Specific glucocorticosteroid compound having anti- inflammatory activity
WO2005047303A2 (en) * 2003-11-12 2005-05-26 Solvay Pharmaceuticals Gmbh NOVEL 17β HYDROXYSTEROID DEHYDROGENASE TYPE I INHIBITORS
JP2007538027A (ja) * 2004-05-21 2007-12-27 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト エストリオール及びエステトロールプロドラッグ類

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5001234A (en) * 1987-04-16 1991-03-19 The Upjohn Company Cyclic hydrocarbons with an aminoalkyl sidechain
US5571933A (en) * 1994-11-17 1996-11-05 Duquesne University Of The Holy Ghost Derivatives of estra 1,3,5(10)triene-17-one, 3-amino compounds and their use
DE19712488A1 (de) * 1997-03-25 1998-10-01 Knoell Hans Forschung Ev Steroidsulfamate, Verfahren zu ihrer Herstellung und Anwendung derselben

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB915129A (en) * 1958-08-04 1963-01-09 Roussel Uclaf New steroid compounds and a process for their preparation
GB1272688A (en) * 1968-12-31 1972-05-03 Rech Chimiques Et Ind Mar Lab Sulphamido-steroids and the preparation thereof
WO2001081364A1 (fr) * 2000-04-24 2001-11-01 Kyowa Hakko Kogyo Co., Ltd. Derives d'estra-1,3,5(10)-triene
JP2003534386A (ja) * 2000-05-31 2003-11-18 シエーリング アクチエンゲゼルシャフト スルホンアミド基を有する化合物及びこれらの化合物を含む医薬組成物
WO2002000679A2 (en) * 2000-06-28 2002-01-03 Novartis Ag 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-beta-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group
WO2005005451A1 (en) * 2003-07-11 2005-01-20 Glaxo Group Limited Specific glucocorticosteroid compound having anti- inflammatory activity
WO2005047303A2 (en) * 2003-11-12 2005-05-26 Solvay Pharmaceuticals Gmbh NOVEL 17β HYDROXYSTEROID DEHYDROGENASE TYPE I INHIBITORS
JP2007538027A (ja) * 2004-05-21 2007-12-27 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト エストリオール及びエステトロールプロドラッグ類

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007538027A (ja) * 2004-05-21 2007-12-27 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト エストリオール及びエステトロールプロドラッグ類

Also Published As

Publication number Publication date
TW200613315A (en) 2006-05-01
PE20060359A1 (es) 2006-05-25
AR050335A1 (es) 2006-10-18
WO2005113574A1 (de) 2005-12-01
UY28909A1 (es) 2005-12-30
SV2006002121A (es) 2006-02-15
PA8633701A1 (es) 2006-07-03
EP1747230A1 (de) 2007-01-31
GT200500121A (es) 2006-01-30
DE102004025966A1 (de) 2005-12-15

Similar Documents

Publication Publication Date Title
US7534780B2 (en) Estradiol prodrugs
US9096639B2 (en) 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylene phenyl derivatives, methods for the production thereof and use thereof for treating diseases
JP6130087B1 (ja) １７−ヒドロキシ−１７−ペンタフルオロエチル−エストラ−４，９（１０）−ジエン−１１−アリール誘導体、その製造方法、その誘導体を利用した諸疾患の治療
JP2007538025A (ja) エストラジオールプロドラッグ
JP5791810B2 (ja) エストラ−１，３，５（１０），１６−テトラエン−３−カルボキサミド誘導体、それらの製造方法、それらを含む医薬製剤および医薬を製造するためのそれらの使用
US20070197488A1 (en) Prodrugs of ERbeta-selective substances, process for their production, and pharmaceutical compositions that contain these compounds
US20050277625A1 (en) Estriol and estetrol prodrugs
CA2789237A1 (en) Progesterone receptor antagonists
JP2007538026A (ja) アンドロゲン作用を有するステロイドプロドラッグ
JP2007538027A (ja) エストリオール及びエステトロールプロドラッグ類
JP5781070B2 (ja) １７−ヒドロキシ−１７−ペンタフルオロエチルエストラ−４，９（１０）−ジエン１１−ベンジリデン誘導体、その製造方法、及び疾患治療のためのその使用
JP2005539016A (ja) 女性用受胎調節及びホルモン置換療法のための高められた抗ゴナドトロピン活性を有するプロゲステロン受容体モジュレーター
US20070123500A1 (en) Prodrugs of ERbeta-selective substances, processes for their preparation and pharmaceutical compositions comprising these compounds
US20050282793A1 (en) Steroid prodrugs with androgenic action
JP2009517426A (ja) ＥＲβ−選択物質のプロドラッグ類、それらの製造方法、及びそれらの化合物を含む医薬組成物
JP2009517427A (ja) ＥＲβ−選択性物質のプロドラッグ、それらを製造する方法およびこれらの化合物を含んでなる医薬組成物
KR20070020454A (ko) 안드로겐 효과를 가지는 스테로이드 프로드러그
NZ622081B2 (en) Estra-1,3,5(10),16-tetraene-3-carboxamide derivatives, process for preparation thereof, pharmaceutical preparations comprising them, and use thereof for production of medicaments
MX2008006855A (en) Prodrugs of er-beta-selective substances method for production thereof and pharmaceutical compositions comprising the same

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080509

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080509

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110607

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20111101